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Issue BRIEF
ISSUES AT THE HEART OF ADVANCING
THE DE-ADOPTION OF LOW-VALUE CARE
Proceedings from an expert roundtable
Identifying and paying for value has become
a recurrent theme of health care reforms. Its
corollary, reducing the prevalence of, and
resources directed to, ineffective or marginally
effective care, has received far less attention.
In July 2016, the University of Pennsylvania’s
Leonard Davis Institute of Health Economics
(LDI) convened a diverse set of national
leaders and stakeholders representing industry,
think-tanks, provider and patient groups,
and academic experts to tackle how health
systems, payers, and providers can spur
the ‘de-adoption’ of medical practices and
technologies no longer considered valuable.
While the roundtable of experts unanimously
supports the need for de-adoption and current
efforts to curb the use of low-value practices
or technologies, they identified four specific
polarities at the heart of the debate about
how best to build the momentum around deadoption, and move it forward. They are:
1) value (targeting ineffective, even harmful,
care or expanding efforts to address care
of limited value)
2) resource allocation (spending less or
redirecting spending)
3) quality improvement (a subset of QI or a
distinct process)
4) level of intervention (policy, payment,
provider, or organization)
In addition to these polarities, several key
questions emerged that form practical next
steps for advancing de-adoption activities. With
an eye toward advancing de-adoption, this brief
summarizes the polarities and questions that

suggest priorities for a future research agenda
and policy-relevant action steps.
The U.S. spends nearly 18% of its GDP ($3.0
trillion, or $9,523 per person) on health care,
more than any other country. According
to the Institute of Medicine, a third of that
spending could be considered wasteful, in that
it does not contribute to improving health.
Nearly one-third of the waste is due to the
provision of ‘unnecessary services,’ which
gives us a sense of the scope of the problem,
but little guidance about which services are
unnecessary, why they are provided, and
what to do about it. The expert roundtable
illuminated the following dimensions that can
help us develop new better frames for moving
the debate forward.

VALUE: TARGETING
INEFFECTIVE OR MARGINALLY
EFFECTIVE CARE?
Whether to target ineffective or marginally
effective care is a key decision in de-adoption
efforts. The value of a service or product is
almost always a function of clinical situation
in which it is used, and capturing that clinical
nuance can be challenging. However, there is
a limited set of services in which that clinical
nuance can be readily and reliably ascertained
to identify useless, or even harmful, care for
de-adoption. The advantage of targeting this
category is the broad support that can be
leveraged around advocating for de-adoption
of services that are useless or harmful. One
study estimated Medicare spending on 26

As background for the roundtable, and to help find a common terminology for
discussions, LDI reviewed the literature on previous attempts to reduce the use
of services that do not improve health. While the process by which ineffective
practices or technologies are abandoned is neither simple nor automatic, even
the language used to describe it is not clear. And language matters, with different
terms often reflecting an unstated focus on one intervention mechanism (for
example, guidelines or payment policy) or one level of decision-making (for
example, at the bedside or formulary). Disinvestment remains the most commonly
used term, but may presuppose that the best way to reduce ineffective care is to
stop paying for it. For the purposes of the roundtable, we chose de-adoption as this
has been suggested as a term to standardize the literature on low-value clinical care,
and is more neutral about how we might advance this objective.
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ADDRESSING THE USE OF
MARGINALLY EFFECTIVE
CARE OFFERS POTENTIALLY
GREATER REWARDS FOR
DE-ADOPTION EFFORTS, AND
CARRIES MUCH HIGHER RISKS.

ineffective services that were easily identifiable,
and readily verifiable, from claims data. The
study estimated that these services comprise
between 0.6% and 2.7% of Medicare spending.
That is a useful baseline about the potential
savings that can be captured by targeting
clearly useless services for de-adoption.
Broadening the targets to situations in which
marginal costs exceeds marginal benefit may
threaten the support for de-adoption initiatives,
because it involves both clinical nuance and
value judgments. On the other hand, targeting
marginally effective care has a much greater
potential to bend the health care spending
curve, because it encompasses a much larger
set of services and spending. Addressing
the use of marginally effective care offers
potentially greater rewards for de-adoption
efforts, and carries much higher risks. It requires
value judgments and trade-offs that may be
politically infeasible, even if it is economically
efficient. But even a small reduction in such
care, if it could be ascertained, has greater
potential to impact health care spending than
even a large reduction in ineffective care.

RESOURCE ALLOCATION:
SPENDING LESS OR
REDIRECTING SPENDING?
A commonly cited reason for de-adoption
is to ‘make room’ for medical innovation that
improves health. Given that innovation is often
expensive (though perhaps of high-value), deadopting services of lesser value would free up
space in budgets to pay for advances in care.
But does de-adoption actually redirect
resources in efficient ways, and what is the
mechanism for doing so? The answer to the
question is important because it provides the
motivation for de-adoption, and gives it some
urgency. In a system of fixed budgets for the
health care system (for example, the UK’s
National Health Service), it is easy to argue that
resources are redirected; it is harder to perceive
these mechanisms in the pluralistic, multi-payer
U.S health care system. It is not the case that
innovation always replaces the technology that
precedes it. For example, the advent of MRIs
did not spur de-adoption of CT scans, but
instead added to spending directed to imaging.
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That additional spending may reduce the
resources available to other important sectors of
the economy, but it does not necessarily crowd
out medical innovation.
In the absence of fixed budgets, one way to
promote efficient redirection of resources is
through risk-based payment models, such as
Accountable Care Organizations (ACOs),
bundled payments, and shared savings
programs. In effect, these models create
incentives for providers to identify and
discard lower-value services in favor of
higher-value ones, because providers are
at risk for the excess spending.

QUALITY IMPROVEMENT:
WHERE DOES
DE-ADOPTION FIT?
How does de-adoption differ from quality
improvement? A common definition of QI is
the “…systematic and continuous actions that
lead to measurable improvement in health
care services and the health status of targeted
patient groups.” To the extent that de-adoption
eliminates harmful care, it clearly overlaps with
the goals of QI. To the extent that it reduces
services that are of marginal benefit, it may fall
outside the scope of QI, especially at a health
system level, unless that system can redirect
resources. Hospital global budgeting may bring
QI and de-adoption into better alignment.
Even when the goals of de-adoption and QI
overlap, the methods may differ. This is an area
of fruitful inquiry, given what we know about
incentivizing behavior change. A different
approach may be needed to encourage a
provider to adopt a practice or process as part
of QI than to stop delivering a specific practice
or service.

AT WHAT LEVEL TO
INTERVENE: POLICY,
PAYMENT, PROVIDER,
OR ORGANIZATION?
A critical question to answer is the appropriate
level at which to target de-adoption efforts,
which may differ depending on the nature of
the service being de-adopted. For example,
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RESEARCHERS NEED TO
BUILD OUT THE SET OF
EXAMPLES THAT ARE
GENERALLY CONSIDERED
HARMFUL OR INEFFECTIVE,
AND YET REMAIN IN USE.

the Choosing Wisely campaign targets
physicians and their patients for conversations
about care identified as low-value by specialty
societies. The campaign grounds its efforts
within a shared decision-making framework
and targets clinical situations in which services
are ineffective or harmful. It remains an open
question whether the cumulative impact
of these bedside conversations can have a
significant impact on the de-adoption of such
care.
At the payer level, simply not providing
coverage for low-value services has a direct
effect on de-adoption. For example, payers can
remove a service from their coverage criteria.
However, using payment policy is inherently a
blunt instrument that may prompt resistance
from consumers and providers.
Acting at a health system or institutional level
may be best for de-adopting some services,
particularly ones that are hospital-based or
device-oriented. However, a problem may arise
at this level if the system has invested many
of its resources in a technology and needs to
recoup its investment.

LOOKING AHEAD:
A RESEARCH AND POLICY
AGENDA TO INCENTIVIZE THE
DE-ADOPTION OF LOW-VALUE
CARE
The roundtable participants identified current
knowledge gaps and areas of inquiry that they
considered to be the most promising in terms
of informing de-adoption initiatives. These six
areas, with explicit acknowledgement of the
framing along the dimensions we discussed,
make up a vibrant research agenda and practical
next steps for advancing de-adoption activities.
What is the full potential of
Choosing Wisely?
Although the provider-led Choosing Wisely
initiative has an important role to play in
promoting the de-adoption of low-value care,
its full potential savings has not been calculated.
The study mentioned earlier focused on 26
ineffective services and the potential savings
for Medicare. But the campaign has more than
300 recommendations. If all Choosing Wisely
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recommendations were implemented, what are
the potential savings, and how far would this
go toward addressing low-value care? What
institutional, social, and individual changes are
needed to realize this potential?
Why are practices still in use
despite evidence of ineffectiveness
or potential for harm?
Researchers need to build out the set of
examples that are generally considered harmful
or ineffective, and yet remain in use, e.g. certain
cancer screenings. A good starting point
might be a subset of the services targeted by
Choosing Wisely, which has had only a marginal
effect on de-adoption. Taken together, these
examples provide the raw data to answer
the questions – Why is this still in practice?
What are the barriers to de-adoption? What
interventions might be most effective?
Conversely, researchers should also build the
set of examples of practices that have been
de-adopted, e.g. non-medical labor induction
prior to 39 weeks. What can be learned about
incentives and appropriate strategies? When
there has been a definitive cliff to the deadoption of a certain procedure in practice,
what was the impetus? What is the common
thread across the examples? What sort of
change - i.e. payment, guidelines – was effective
in stopping a practice?
How do theories of individual
and institutional behavior change
apply to de-adoption?
Researchers should look to theories of behavior
change to understand how to design effective
interventions, especially considering that deadoption entails stopping an existing practice.
How do behavioral economic principles of
loss aversion and discounting of long-term
gains affect providers’ decisions to de-adopt?
How can framing be used to affect the way
consumers and providers react to de-adoption
activities? What is the role of social norms
and feedback? On an institutional level, can
diffusion of innovation theory help guide deadoption (the final but rarely discussed phase
of diffusion)? Theories are important, and
different models of behavior change might be
appropriate, depending on the specific practice
and level being targeted.
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How can new risk-sharing payment
models and insurance design
incentivize de-adoption?
New risk-sharing payment models provide
an opportunity to understand and influence
incentives for the de-adoption of low-value
care. Researchers should analyze the utilization
of low-value services in ACOs, as well as
their non-ACO counterparts. The virtual or
real infrastructure of an ACO may provide a
necessary framework for integrating a multilevel intervention to de-adopt certain services,
especially if that ACO can redirect its finite
resources to more effective care.
Risk-sharing relationships and entities are
also promising vehicles for changing provider
incentives. As one roundtable participant said:
“If we can pay farmers not to plant corn, we
could pay cardiologists to not put in stents.”
Value-based insurance design is gaining
prominence as a way to align patient costsharing with the effectiveness of treatments.
Simply put, it encourages patients to use
services when the clinical benefits exceed the
cost (by reducing or eliminating cost-sharing)
and discourages the use of services of marginal
benefit (by increasing a patient’s out-of-pocket
costs). This improves upon the strategy of
simply not paying for a service by letting people
choose between different plans that have
different thresholds about low-value care. This
must be coupled with greater transparency
about the ‘value’ of different services.
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How to determine where and when to
intervene?
Researchers should develop a de-adoption
framework that separates out the different levels
at which to intervene – i.e. policy, organizational,
payment, provider– and integrates them into a
cohesive strategy. Depending on the practice,
it may be that one level is targeted, or that
multiple levels are targeted, either at the same
time or sequentially. How might interventions
interact with each other? Is a ‘Stages of Change’
model useful in assessing readiness for change,
and laying the groundwork at different levels
over time? This ‘five ways to achieve deadoption of low-value care’ would marshal
existing information but in a new way.
What does value mean to patients?
A missing, though essential piece in the deadoption discussion is a better understanding
of ‘value’ from a consumer or patient point
of view. It is key to gaining consensus about
what to de-adopt, and critical to the success of
de-adoption initiatives. As the National Health
Council notes, patient perspectives on value
can differ significantly from that of physicians
and payers, often integrating considerations
beyond clinical outcomes and cost, such as how
a treatment can help patients achieve personal
goals. Researchers should build upon existing
qualitative evidence about patient perspectives
on value and apply it directly to de-adoption
activities. It might help explain why services of
little to no value continue to be offered. This
evidence could help gain consensus on services
to target, and engage consumer and patients in
de-adoption activities.
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